From professional translators, enterprises, web pages and freely available translation repositories.
dette tillader efterfølgende brug af andre godkendte revers transkriptase inhibitorer.
these thymidine analogue mutations alone do not cause high-level cross-resistance to any of the other nucleosides, allowing for the subsequent use of any of the other approved reverse transcriptase inhibitors.
farmakoterapeutisk klassifikation: antivirale midler til systemisk brug, nukleosid og nukleotid revers transkriptase-hæmmere
pharmacotherapeutic group: antivirals for systemic use, nucleoside and nucleotide reverse transcriptase inhibitors
emtricitabintriphosphat og tenofovirdiphosphat hæmmer kompetitivt hiv 1-revers transkriptase, hvilket resulterer i dna-kædeblokering.
emtricitabine triphosphate and tenofovir diphosphate competitively inhibit hiv-1 reverse transcriptase, resulting in dna chain termination.